Biofire defense supply of reagents and analyzers lease

Active Awarded Last action

Contract number
HT941026FE081
Awardee
Awarding agency
Obligated
$0

Award facts

Contract value 0% obligated
$968,331.59 Current and potential, with all options
Completion date 6% complete
Current and potential, with all options
Contracting staff
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Not Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
LEWIS MCCHORD, WA 98431, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency issued a delivery order to Biofire Defense LLC on October 1, 2026, with a ceiling value of $968,331.59 for supply of reagents and analyzers under lease, with an ultimate completion date of September 30, 2027.

The order is issued under Biofire Defense's Defense Health Agency IDC supporting equipment lease and reagent supply for the Madigan Army Medical Center Department of Pathology. Place of performance is Lewis-McChord, Washington. Pricing is firm fixed price with no set-aside applied.

Quick answers

Who was awarded contract HT941026FE081?

HT941026FE081 was awarded to Biofire Defense LLC by Defense Health Agency (Department of Defense) on October 1, 2026.

How much is contract HT941026FE081 worth?

The government has obligated $0 on HT941026FE081. Its current value, with exercised options, is $968,332.

Is contract HT941026FE081 an order under another contract?

Yes. HT941026FE081 is a delivery order under W81K0225DA010, an indefinite delivery contract.

Was contract HT941026FE081 competed?

The extent of competition for HT941026FE081 was not competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award